MIR4712: A Potential Drug Target and Biomarker (G100616396)
MIR4712: A Potential Drug Target and Biomarker
Mir4712 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is miR-4712, and it is a microRNA (miRNA) that plays a crucial role in regulating gene expression. According to research, MIR4712 has been linked to a number of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. As a result, it has gained significant interest as a potential drug target and biomarker.
The discovery of MIR4712 as a potential drug target stems from its ability to regulate the activity of several oncogenes, which are genes that promote cancer growth and development. MIR4712 has been shown to inhibit the activity of several oncogenes, including the PI3K/Akt signaling pathway, which is a well-established regulator of cancer growth.
In addition to its potential as a drug target, MIR4712 has also been shown to be a potential biomarker for several diseases. For example, MIR4712 has been shown to be downregulated in the brains of individuals with Alzheimer's disease, a neurodegenerative disease. This suggests that MIR4712 may be a useful biomarker for diagnosing and monitoring the progression of this disease.
MIR4712 has also been shown to be downregulated in the blood vessels of individuals with cardiovascular disease, which suggests that it may be a useful biomarker for diagnosing and monitoring the progression of this disease.
The potential uses of MIR4712 as a drug target and biomarker make it an attractive candidate for further research. Further studies are needed to fully understand its mechanisms of action and its potential as a drug and biomarker.
In conclusion, MIR4712 is a protein that has shown promise as a potential drug target and biomarker. Further research is needed to fully understand its mechanisms of action and its potential as a therapeutic intervention.
Protein Name: MicroRNA 4712
The "MIR4712 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4712 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723 | MIR4724 | MIR4725 | MIR4726 | MIR4727 | MIR4728 | MIR4729 | MIR4730 | MIR4731 | MIR4732 | MIR4733 | MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746 | MIR4747 | MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754 | MIR4755 | MIR4756 | MIR4757 | MIR4758 | MIR4759 | MIR4760 | MIR4761 | MIR4762 | MIR4763 | MIR4764 | MIR4765 | MIR4766 | MIR4767 | MIR4768 | MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491
